Epidemiology of the plasma-cell disorders.
暂无分享,去创建一个
[1] S. Vincent Rajkumar,et al. Monoclonal gammopathy of undetermined significance , 2013, Radiopaedia.org.
[2] U. Axelsson,et al. Frequency of pathological proteins (M-components) om 6,995 sera from an adult population. , 2009, Acta medica Scandinavica.
[3] M. Greaves,et al. IgA lambda myeloma presenting concurrently in identical twins with subsequent transformation to 'aggressive phase' in one. , 2008, Clinical and laboratory haematology.
[4] M. Tomonaga,et al. Late hematological effects in the atomic bomb survivors , 2007 .
[5] P. Infante. Benzene Exposure and Multiple Myeloma , 2006, Annals of the New York Academy of Sciences.
[6] A. Lanier,et al. Cancer in Alaska Native people, 1969-2003. , 2006, Alaska medicine.
[7] A. Dispenzieri,et al. Prevalence of monoclonal gammopathy of undetermined significance. , 2006, The New England journal of medicine.
[8] R. Hoover,et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. , 2005, Blood.
[9] J. Cerhan,et al. Anthropometric Characteristics and Risk of Multiple Myeloma , 2005, Epidemiology.
[10] T. Therneau,et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. , 2005, Blood.
[11] D. Weisenburger,et al. Phenotypic heterogeneity in multiple myeloma families. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] T. Therneau,et al. Incidence of multiple myeloma in Olmsted County, Minnesota , 2004, Cancer.
[13] L. Hagmar,et al. Allergic conditions and risk of hematological malignancies in adults: a cohort study , 2004, BMC public health.
[14] D. Bevan,et al. A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK , 2004, British journal of haematology.
[15] T. Therneau,et al. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. , 2004, Mayo Clinic proceedings.
[16] E. Kliewer,et al. Dietary fish intake and risk of leukaemia, multiple myeloma, and non-Hodgkin lymphoma. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[17] E. Giné,et al. Smoldering multiple myeloma: natural history and recognition of an evolving type , 2003, British journal of haematology.
[18] D. Silverman,et al. Multiple myeloma and diesel and other occupational exposures in swedish construction workers , 2003, International journal of cancer.
[19] R. Hayes,et al. Occupation, pesticide exposure and risk of multiple myeloma. , 2003, Scandinavian journal of work, environment & health.
[20] M. Hauptmann,et al. Cancer incidence in the U.S. radiologic technologists health study, 1983–1998 , 2003 .
[21] Kenneth C. Anderson,et al. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group , 2003, British journal of haematology.
[22] C. Muirhead,et al. Follow up of mortality and incidence of cancer 1952–98 in men from the UK who participated in the UK's atmospheric nuclear weapon tests and experimental programmes , 2003, Occupational and environmental medicine.
[23] M. Hauptmann,et al. Cancer incidence in the US radiologic technologists health study, 1983-1998. , 2002, Cancer.
[24] C. Klersy,et al. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Terry M Therneau,et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. , 2002, The New England journal of medicine.
[26] T. Sonoda,et al. Meta-analysis of multiple myeloma and benzene exposure. , 2001, Journal of epidemiology.
[27] D. Weisenburger,et al. Familial multiple myeloma: a family study and review of the literature. , 2001, Journal of the National Cancer Institute.
[28] A. Olshan,et al. Diagnostic radiation and the risk of multiple myeloma (United States) , 2001, Cancer Causes & Control.
[29] R. Hayes,et al. Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States , 2001, Cancer Causes & Control.
[30] M. Dimopoulos,et al. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. , 2000, Blood.
[31] R. Hayes,et al. Socioeconomic status and multiple myeloma among US blacks and whites. , 2000, American journal of public health.
[32] N. Brautbar,et al. Benzene and multiple myeloma: appraisal of the scientific evidence. , 2000, Blood.
[33] D. Richardson,et al. A case control study of multiple myeloma at four nuclear facilities. , 2000, Annals of epidemiology.
[34] M. Thun,et al. Deaths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study (United States) , 1999, Cancer Causes & Control.
[35] A. Gandarillas,et al. Leukemia, lymphomas, and myeloma mortality in the vicinity of nuclear power plants and nuclear fuel facilities in Spain. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[36] K. Cantor,et al. Mortality among aerial pesticide applicators and flight instructors: follow-up from 1965-1988. , 1999, American journal of industrial medicine.
[37] R. Bataille,et al. Familial multiple myeloma: report of fifteen families , 1999, British journal of haematology.
[38] R. Hayes,et al. Multiple myeloma and family history of cancer among blacks and whites in the U.S. , 1999, Cancer.
[39] G. Schreiber,et al. Low prevalence of flower cells in U.S.A. blood donors infected with human T‐lymphotrophic virus types I and II , 1999, British journal of haematology.
[40] J. K. Wendt,et al. Update of the Texaco mortality study 1947-93: Part II. Analyses of specific causes of death for white men employed in refining, research, and petrochemicals. , 1999, Occupational and environmental medicine.
[41] P. Wiernik,et al. Anticipation in familial plasma cell dyscrasias , 1998, British journal of haematology.
[42] V. Beral,et al. Cancer mortality in relation to monitoring for radionuclide exposure in three UK nuclear industry workforces. , 1998, British Journal of Cancer.
[43] O. Nanni,et al. Multiple Myeloma and Work in Agriculture: Results of a Case-Control Study in Forlì, Italy , 1998, Cancer Causes & Control.
[44] H. Cohen,et al. Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly. , 1998, The American journal of medicine.
[45] R. Kyle,et al. Primary plasmacytoma at the site of exit wounds after electrical injury , 1998, American journal of hematology.
[46] Daniel S. Miller,et al. Cancer incidence and mortality, 1973‐1995 , 1998 .
[47] S. Khuder,et al. Meta-analyses of multiple myeloma and farming. , 1997, American journal of industrial medicine.
[48] D. Savitz,et al. Lymphoma and multiple myeloma mortality in relation to magnetic field exposure among electric utility workers. , 1997, American journal of industrial medicine.
[49] O. Wong,et al. Multiple myeloma and benzene exposure in a multinational cohort of more than 250,000 petroleum workers. , 1997, Regulatory toxicology and pharmacology : RTP.
[50] R. Hayes,et al. Multiple myeloma among Blacks and Whites in the United States: role of cigarettes and alcoholic beverages , 1997, Cancer Causes & Control.
[51] M. Dimopoulos,et al. Prognostic features of asymptomatic multiple myeloma , 1997, British journal of haematology.
[52] Polednak Ap. Trends in cancer incidence in Connecticut. , 1997 .
[53] A. Engel,et al. Does benzene cause multiple myeloma? An analysis of the published case-control literature. , 1996, Environmental health perspectives.
[54] S. Salmon,et al. Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] P. Laake,et al. Incidence and risk factors of cancer among men and women in Norwegian agriculture. , 1996, Scandinavian journal of work, environment & health.
[56] J. Riggs. Increasing multiple myeloma mortality rates in the elderly: demonstration of increasing dependency with increasing age upon age group population size , 1995, Mechanisms of Ageing and Development.
[57] M. Kogevinas,et al. Pooled reanalysis of cancer mortality among five cohorts of workers in wood-related industries. , 1995, Scandinavian Journal of Work, Environment and Health.
[58] O. Wong,et al. Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene. , 1995, Occupational and environmental medicine.
[59] C. la Vecchia,et al. Epidemiological evidence on hair dyes and the risk of cancer in humans. , 1995, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[60] J. Riggs. Increasing multiple myeloma mortality among the elderly: a manifestation of aging and differential survival , 1995, Mechanisms of Ageing and Development.
[61] P. Smith,et al. Cancer mortality and morbidity among plutonium workers at the Sellafield plant of British Nuclear Fuels , 1994, British Journal of Cancer.
[62] A. Polednak. Trends in cancer incidence in Connecticut, 1935–1991 , 1994, Cancer.
[63] D. R. Lewis,et al. Multiple myeloma among blacks and Whites in the United States: the role of chronic antigenic stimulation , 1994, Cancer Causes & Control.
[64] G. Friedman,et al. Obesity and multiple myeloma , 1994, Cancer Causes & Control.
[65] W. O'Fallon,et al. Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with a review of the trend since 1945. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[66] W. O'Fallon,et al. Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma , 1994, British journal of haematology.
[67] H. Dohy,et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. , 1994, Radiation research.
[68] J. Viel,et al. Lymphoma, multiple myeloma and leukaemia among French farmers in relation to pesticide exposure. , 1993, Social science & medicine.
[69] H. Morrison,et al. Multiple myeloma mortality and agricultural practices in the Prairie provinces of Canada. , 1993, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[70] T. Koepsell,et al. A case-control study of multiple myeloma and occupation. , 1993, American journal of industrial medicine.
[71] L. Brown,et al. Pesticide exposures and multiple myeloma in Iowa men , 1993, Cancer Causes & Control.
[72] T. Koepsell,et al. Epidemiology of the M-component immunoglobulin types of multiple myeloma , 1993, Cancer Causes & Control.
[73] Y. Yoshimoto,et al. Monoclonal gammopathy in atomic bomb survivors. , 1993, Radiation research.
[74] L. Brown,et al. Hair dye use and multiple myeloma in white men. , 1992, American journal of public health.
[75] J. Olsen,et al. Occupational risk factors for multiple myeloma among Danish men , 1992, Cancer Causes & Control.
[76] L. Brown,et al. Alcohol consumption and risk of leukemia, non-Hodgkin's lymphoma, and multiple myeloma. , 1992, Leukemia research.
[77] J. Olsen,et al. Multiple myeloma among Danish women: employment history and workplace exposures , 1992, Cancer Causes & Control.
[78] D. Weisenburger,et al. Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia. , 1992, American journal of public health.
[79] S. Wacholder,et al. Is cigarette smoking a risk factor for non-Hodgkin's lymphoma or multiple myeloma? Results from the Lutheran Brotherhood Cohort Study. , 1992, Leukemia research.
[80] A. Linos,et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. , 1992, Blood.
[81] M. Eriksson,et al. Occupational and other environmental factors and multiple myeloma: a population based case-control study. , 1992, British journal of industrial medicine.
[82] S. Mayne,et al. The time trends of multiple myeloma in Connecticut, 1935–1987 , 1992, International journal of cancer.
[83] J. Holland,et al. Socioeconomic status and cancer survival. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[84] R. Hoover,et al. Diagnostic x-ray procedures and risk of leukemia, lymphoma, and multiple myeloma. , 1991, JAMA.
[85] W. L. Beeson,et al. History of cigarette smoking and risk of leukemia and myeloma: results from the Adventist health study. , 1990, Journal of the National Cancer Institute.
[86] A. Dudley,et al. Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting. , 1990, The Journal of laboratory and clinical medicine.
[87] Alan D. Lopez,et al. International Trends in Cancer Mortality in France, West Germany, Italy, Japan, England and Wales, and the United States a , 1990, Annals of the New York Academy of Sciences.
[88] J. Schwartz. Multinational Trends in Multiple Myeloma , 1990, Annals of the New York Academy of Sciences.
[89] J. Cuzick. International Time Trends for Multiple Myeloma , 1990, Annals of the New York Academy of Sciences.
[90] B. Goldstein. Is Exposure to Benzene a Cause of Human Multiple Myeloma? a , 1990, Annals of the New York Academy of Sciences.
[91] Fabio Levi,et al. Trends in multiple myeloma. , 1990, International journal of cancer.
[92] A. Mclean. International trends in cancer mortality , 1990, The Lancet.
[93] A. Lopez,et al. International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA , 1990, The Lancet.
[94] H. Kato,et al. Cancer risk among atomic bomb survivors. The RERF Life Span Study. Radiation Effects Research Foundation. , 1990, JAMA.
[95] D. Heudes,et al. Multiple myeloma: epidemiological features in a well-defined population in Burgundy, France. , 1989, International journal of epidemiology.
[96] J. Olsen,et al. Trends in the incidence of multiple myeloma in Denmark 1943–1982: A study of 5500 patients , 1989, European journal of haematology.
[97] R. Doll,et al. Further follow up of mortality and incidence of cancer in men from the United Kingdom who participated in the United Kingdom's atmospheric nuclear weapon tests and experimental programmes. , 1988, BMJ.
[98] R. Doll,et al. A summary of mortality and incidence of cancer in men from the United Kingdom who participated in the United Kingdom's atmospheric nuclear weapon tests and experimental programmes , 1988, British medical journal.
[99] A. Olshan,et al. Antigenic stimulation and the occurrence of multiple myeloma. , 1987, American journal of epidemiology.
[100] David Forman,et al. Cancer near nuclear installations , 1987, Nature.
[101] J. Crowley,et al. The effects of distance from primary treatment centers on survival among patients with multiple myeloma. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[102] D. Silverman,et al. Cancer incidence and mortality trends among whites in the United States, 1947-84. , 1987, Journal of the National Cancer Institute.
[103] J. Mclaughlin,et al. A case-control study of multiple myeloma in whites: chronic antigenic stimulation, occupation, and drug use. , 1987, Cancer research.
[104] S. Grufferman,et al. Role of immune stimulation in the etiology of multiple myeloma: A case control study , 1987, American journal of hematology.
[105] P G Smith,et al. Mortality of workers at the Sellafield plant of British Nuclear Fuels. , 1986, British medical journal.
[106] K. Wiklund,et al. Trends in cancer risks among Swedish agricultural workers. , 1986, Journal of the National Cancer Institute.
[107] E. DeLong,et al. Multiple myeloma and family history of cancer a case—control study , 1985, Cancer.
[108] J. M. Johnston,et al. Socioeconomic status and risk of multiple myeloma. , 1985, Journal of epidemiology and community health.
[109] W. Blattner,et al. Mortality from multiple myeloma among North Carolina furniture workers. , 1985, Journal of the National Cancer Institute.
[110] A. Smith,et al. Malignant lymphoma and multiple myeloma linked with agricultural occupations in a New Zealand Cancer Registry-based study. , 1985, American journal of epidemiology.
[111] J. Cuzick,et al. Comparison of trends in the incidence of multiple myeloma in Malmö, Sweden, and other countries, 1950-1979. , 1984, The New England journal of medicine.
[112] M. Ichimaru,et al. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow. , 1982, Journal of the National Cancer Institute.
[113] M. Vicariot,et al. Monoclonal gammopathies in the adult population of Finistère, France. , 1982, Journal of clinical pathology.
[114] Y. Shoenfeld,et al. Familial multiple myeloma. A review of thirty-seven families. , 1982, Postgraduate medical journal.
[115] V. E. Archer. Cancer mortality in Iowa farmers. , 1981, Journal of the National Cancer Institute.
[116] L. Burmeister. Cancer mortality in Iowa farmers, 1971-78. , 1981, Journal of the National Cancer Institute.
[117] J. Cuzick. Radiation-induced myelomatosis. , 1981, The New England journal of medicine.
[118] R. Kyle,et al. Smoldering multiple myeloma. , 1980, The New England journal of medicine.
[119] E. Kagan,et al. Asbestos-associated neoplasms of B cell lineage. , 1979, The American journal of medicine.
[120] M. Ende. Multiple myeloma: a cluster in Virginia? , 1979, Virginia medical.
[121] R. Kyle,et al. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. , 1978, The American journal of medicine.
[122] N. Asal,et al. Multiple myeloma in Oklahoma: racial, age, sex, geographic and time variations. , 1976, Southern medical journal.
[123] G. Matanoski,et al. The current mortality rates of radiologists and other physician specialists: specific causes of death. , 1975, American journal of epidemiology.
[124] R. Kyle,et al. Familial myeloma. Report of eight families and a study of serum proteins in their relatives. , 1974, The American journal of medicine.
[125] L. Elveback,et al. Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. , 1972, Blood.
[126] M. Aksoy,et al. Details of blood changes in 32 patients with pancytopenia associated with long-term exposure to benzene , 1972, British journal of industrial medicine.
[127] S. Milham,et al. Leukemia and multiple myeloma in farmers. , 1971, American journal of epidemiology.
[128] C. Heath,et al. Multiple myeloma. A community cluster. , 1970, JAMA.
[129] L. Kurland,et al. Multiple myeloma in Olmsted County, Minnesota, 1945-1964. , 1969, Blood.
[130] E. Lewis. Leukemia, Multiple Myeloma, and Aplastic Anemia in American Radiologists , 1963, Science.
[131] B. Macmahon,et al. The incidence of multiple myeloma. , 1956, Journal of chronic diseases.
[132] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD, , 2006 .
[133] R. Bergström,et al. Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden) , 2004, Cancer Causes & Control.
[134] J. Mclaughlin,et al. A prospective study of tobacco use and multiple myeloma: evidence against an association , 2004, Cancer Causes & Control.
[135] Marshall A Lichtman,et al. Familial (inherited) leukemia, lymphoma, and myeloma: an overview. , 2004, Blood cells, molecules & diseases.
[136] L. Brown,et al. Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma , 2004, Cancer Causes & Control.
[137] L. Rybicki,et al. Skeletal trauma preceding the development of plasma cell dyscrasia , 2003, Medical oncology.
[138] O. Wong. Is There a Causal Relationship Between Exposure to Diesel Exhaust and Multiple Myeloma? , 2003, Toxicological reviews.
[139] Terry M Therneau,et al. Review of 1027 patients with newly diagnosed multiple myeloma. , 2003, Mayo Clinic proceedings.
[140] I. Lundberg,et al. Mortality and cancer incidence among Swedish paint industry workers with long-term exposure to organic solvents. , 1998, Scandinavian journal of work, environment & health.
[141] R. Mckenna,et al. Leukemias, myeloma, and other lymphoreticular neoplasms , 1995, Cancer.
[142] T. Koepsell,et al. Exposure to hair-coloring products and the risk of multiple myeloma. , 1994, American journal of public health.
[143] H. Kolstad,et al. Cancer incidence in the Danish reinforced plastics industry. , 1993, IARC scientific publications.
[144] M. Dimopoulos,et al. Risk of disease progression in asymptomatic multiple myeloma. , 1993, The American journal of medicine.
[145] P. Pasini,et al. Familial occurrence of multiple myeloma and monoclonal gammopathy of undetermined significance in 5 siblings. , 1990, Haematologica.
[146] G. R. Petersen,et al. Mortality of workers at the Hanford site: 1945-1981. , 1989, Health physics.
[147] T. Koepsell,et al. B cell neoplasms and occupational asbestos exposure. , 1988, American journal of industrial medicine.
[148] M. Fredriksson,et al. Multiple myeloma and engine exhausts, fresh wood, and creosote: a case-referent study. , 1987, American journal of industrial medicine.
[149] J. Spinelli,et al. Multiple myeloma, leukemia, and cancer of the ovary in cosmetologists and hairdressers. , 1984, American journal of industrial medicine.
[150] A. Kutlar,et al. Clinical observations showing the role of some factors in the etiology of multiple myeloma. A study in 7 patients. , 1984, Acta haematologica.
[151] R. Kyle,et al. Multiple myeloma. Houses and spouses. , 1983, Cancer.
[152] J. Peters,et al. Multiple myeloma in cosmetologists. , 1982, American journal of industrial medicine.
[153] A. Linos,et al. Incidence and secular trend of multiple myeloma in Olmsted County, Minnesota: 1965-77. , 1981, Journal of the National Cancer Institute.